MedPath

Study of Tumor and Blood Samples From Women With Breast Cancer

Conditions
Breast Cancer
Registration Number
NCT00897728
Lead Sponsor
Institut Curie
Brief Summary

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is looking at tumor and blood samples from women with breast cancer.

Detailed Description

OBJECTIVES:

Primary

* Assess relapse locally or remotely using biomarkers collected from primary tumor and blood samples from women with breast cancer during the first 2 years after diagnosis.

Secondary

* Evaluate all relapses.

* Assess survival without relapse.

* Determine correlation between biomarkers and relapse.

OUTLINE: Primary tumor and blood samples collected during usual care of patients during the first 2 years after diagnosis are analyzed for biomarkers useful in monitoring and diagnosing breast cancer.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
180
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Local or remote relapse as assessed by biomarkers in tissue and blood samples collected during the first 2 years after diagnosis
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institut Curie Hopital

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath